Evidence map›Paper›PMID 35309330›Full record

ArticleFrontiers in immunology2022

Succinate Is a Natural Suppressor of Antiviral Immune Response by Targeting MAVS.

Yue Xiao, Xinyi Chen, Zhun Wang, Jiazheng Quan, Xibao Zhao, Haimei Tang, Han Wu, Qianqian Di, Zherui Wu, Weilin Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yue XiaoDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Xinyi ChenDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Zhun WangTechnological Center, Changchun Customs, Changchun, China.
Jiazheng QuanDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Xibao ZhaoDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Haimei TangDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Han WuDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Qianqian DiDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Zherui WuDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Weilin ChenDepartment of Immunology, School of Medicine, Shenzhen University, Shenzhen, China.
Shenzhen University · CNChangchun University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Succinate is at the crossroads of multiple metabolic pathways and plays a role in several immune responses acting as an inflammation signal. However, whether succinate regulates antiviral immune response remains unclear. Here, we found that the production of succinate was reduced in RAW264.7 cells during vesicular stomatitis virus (VSV) infection. Using diethyl succinate to pretreat the mouse peritoneal macrophages and RAW264.7 cells before VSV infection, the production of interferon-β (IFN-β), chemokine (C-X-C motif) ligand 10 (CXCL-10), and IFN-stimulated genes 15 (ISG15) was significantly decreased, following which the VSV replication in diethyl succinate-pretreated cells was obviously increased. Moreover, succinate decreased the expression of IFN-β in serum, lung, and spleen derived from the VSV-infected mice. The overall survival rate in the VSV-infected mice with diethyl succinate pretreatment was also remarkably downregulated. Furthermore, we identified that succinate inhibited the activation of MAVS-TBK1-IRF3 signaling by suppressing the formation of MAVS aggregates. Our findings provide previously unrecognized roles of succinate in antiviral immune response and establish a novel link between metabolism and innate immune response.

Indexed as

Succinic AcidAnimalsImmunity, InnateInterferon-betaMiceVesicular stomatitis Indiana virusInterferon-betaSuccinic Acidantiviral immune responseMAVSmetabolismsuccinateVSV

Identifiers

PMID35309330
PMCPMC8924363
OpenAlexW4214916863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.